Skip to main content
. 2016 Feb 24;8(10):16190–16201. doi: 10.18632/oncotarget.7668

Table 2. Responses and toxicities to chemoradiotherapy of head and neck squamous cell carcinoma patients.

Variable Ideal or mild Non-ideal, moderate or severe
Type of response or grade of toxicity N (%) Type of response or grade of toxicity N (%)
Response rate CR+PR 68 (93.2) SD 5 (6.8)
CR 15 (20.5) PR+SD 58 (79.5)
Gastrointestinal toxicities
 Nausea G0+G1 37 (42.0) G2+G3 51 (58.0)
 Vomiting G0+G1 59 (67.0) G2+G3+G4 29 (33.0)
Hematologic toxicities
 Anemia G0+G1 37 (44.0) G2+G3+G4 47 (56.0)
 Leukopenia G0+G1 47 (56.0) G2+G3+G4 37 (44.0)
 Neutropenia G0+G1+G2 67 (79.8) G3+G4 17 (20.2)
 Lymphopenia G0+G1+G2 42 (50.0) G3+G4 42 (50.0)
 Thrombocytopenia G0 54 (64.3) G1+G2+G3+G4 30 (35.7)
Nephrotoxicity G0+G1 36 (52.2) G2+G3+G4+G5 33 (47.8)
Ototoxicity G0+G1 36 (51.4) G2+G3+G4 34 (48.6)

(N) number of patients; (CR) complete response; (PR) partial response; (SD) stable disease; (G) grade of toxicity. The total number of patients differed from the total quoted in the study (n= 90), because it was not possible to obtain consistent information about response rate, nausea and vomiting, hematologic exams, glomerular filtration rate or audiometry test after chemoradiotherapy in some cases.